LiverRight Introduces First National Virtual Clinic for Liver Disease Treatment
LiverRight™, a healthcare service provider based in Cincinnati, has made a groundbreaking announcement by launching the first national virtual clinic specifically designed for liver disease treatment. This innovative clinic aims to address the pressing issue of accessibility and timely diagnosis in the U.S. hepatology community, where approximately 80 million people are impacted by various forms of liver disease. However, only about 5 million adults have received a formal diagnosis.
The LiverRight Hepatology Clinic is committed to providing swift access to care, with same-week appointment availability—a stark contrast to the typical months-long wait for specialist consultations. With this initiative, LiverRight strives to compress the time it takes for patients to receive both diagnosis and treatment initiation, a critical factor in managing liver diseases such as chronic hepatitis, alcoholic liver disease, fatty liver disease (FLD), and cirrhosis.
Brandon Tudor, CEO and co-founder of LiverRight, stressed the importance of addressing liver disease early to avoid serious complications, including liver cancer and the potential need for a transplant, a process hampered by the limited availability of donor organs. According to Tudor, "Liver disease in America is under-diagnosed, and if not identified and treated early, it can lead to more severe health issues."
Particularly concerning is the situation for patients suffering from metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD). Affecting around 30% of the adult U.S. population, MASLD is recognized as the leading cause of cirrhosis and liver cancer among women, and the second leading cause for men. Moreover, the more severe stage, metabolic dysfunction-associated steatohepatitis (MASH), presents an even greater risk. Many Americans are also living with viral hepatitis, which contributes to liver inflammation and further complicates health outcomes.
A recent study published on January 6, 2025, in Hepatology reveals the high costs associated with cirrhosis compared to other chronic diseases. It identified patients with cirrhosis incur significantly higher healthcare costs, including 21.7% overall and 59.0% in pharmaceutical costs per month. These statistics underscore the urgent need for effective, accessible treatment options like those offered by LiverRight.
As part of a broader network, the LiverRight Virtual Clinic aims to provide longitudinal care for all forms of liver disease, incorporating diagnostic testing, blood tests, and liver imaging. Their team will guide patients in implementing lifestyle changes such as diet and exercise, alongside prescribing necessary medications for conditions like MASLD and managing viral hepatitis.
LiverRight is also a proud member of the Second Cohort in the Venture Velocity Program from Cintrifuse, an initiative aimed at nurturing entrepreneurship and innovation within the Cincinnati area. J.B. Kropp, CEO of Cintrifuse, welcomed LiverRight and expressed excitement about their potential impact in the field of liver disease treatment. He noted, "Their innovative approach will undoubtedly make waves and we look forward to supporting them in scaling their impact and improving access to life-saving care."
This revolutionary clinic is prepared to change the landscape of liver disease treatment in America by ensuring timely diagnosis and comprehensive care. As they continue to expand their services across the country, LiverRight is dedicated to making a significant difference in the lives of those suffering from liver issues. Their mission is clear: to facilitate early diagnosis, offer same-week appointments, and provide continuous care with the goal of achieving superior health outcomes for both patients and healthcare payers.
For more information about this initiative, visit www.liverright.com.
The LiverRight Hepatology Clinic is committed to providing swift access to care, with same-week appointment availability—a stark contrast to the typical months-long wait for specialist consultations. With this initiative, LiverRight strives to compress the time it takes for patients to receive both diagnosis and treatment initiation, a critical factor in managing liver diseases such as chronic hepatitis, alcoholic liver disease, fatty liver disease (FLD), and cirrhosis.
Brandon Tudor, CEO and co-founder of LiverRight, stressed the importance of addressing liver disease early to avoid serious complications, including liver cancer and the potential need for a transplant, a process hampered by the limited availability of donor organs. According to Tudor, "Liver disease in America is under-diagnosed, and if not identified and treated early, it can lead to more severe health issues."
Particularly concerning is the situation for patients suffering from metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD). Affecting around 30% of the adult U.S. population, MASLD is recognized as the leading cause of cirrhosis and liver cancer among women, and the second leading cause for men. Moreover, the more severe stage, metabolic dysfunction-associated steatohepatitis (MASH), presents an even greater risk. Many Americans are also living with viral hepatitis, which contributes to liver inflammation and further complicates health outcomes.
A recent study published on January 6, 2025, in Hepatology reveals the high costs associated with cirrhosis compared to other chronic diseases. It identified patients with cirrhosis incur significantly higher healthcare costs, including 21.7% overall and 59.0% in pharmaceutical costs per month. These statistics underscore the urgent need for effective, accessible treatment options like those offered by LiverRight.
As part of a broader network, the LiverRight Virtual Clinic aims to provide longitudinal care for all forms of liver disease, incorporating diagnostic testing, blood tests, and liver imaging. Their team will guide patients in implementing lifestyle changes such as diet and exercise, alongside prescribing necessary medications for conditions like MASLD and managing viral hepatitis.
LiverRight is also a proud member of the Second Cohort in the Venture Velocity Program from Cintrifuse, an initiative aimed at nurturing entrepreneurship and innovation within the Cincinnati area. J.B. Kropp, CEO of Cintrifuse, welcomed LiverRight and expressed excitement about their potential impact in the field of liver disease treatment. He noted, "Their innovative approach will undoubtedly make waves and we look forward to supporting them in scaling their impact and improving access to life-saving care."
This revolutionary clinic is prepared to change the landscape of liver disease treatment in America by ensuring timely diagnosis and comprehensive care. As they continue to expand their services across the country, LiverRight is dedicated to making a significant difference in the lives of those suffering from liver issues. Their mission is clear: to facilitate early diagnosis, offer same-week appointments, and provide continuous care with the goal of achieving superior health outcomes for both patients and healthcare payers.
For more information about this initiative, visit www.liverright.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.